{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:29:33Z","timestamp":1779931773033,"version":"3.53.1"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T00:00:00Z","timestamp":1201737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objective: <\/jats:bold> Antimitochondrial antibodies (AMA) are the hallmark in primary biliary cirrhosis (PBC); nevertheless, it has long been recognized that 5\u201310% patients with typical features compatible with PBC do not have detectable AMA, and they were referred to as \u2018AMA\u2010negative PBC\u2019. This study aimed to evaluate whether AMA\u2010negative\/positive PBC represents different clinical entities.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> We compared the clinical, laboratory, percentage of regulatory T cells (Tregs) in peripheral blood, liver biopsy features and response to treatment of the two groups of patients. The first group was comprised of 12 patients with \u2018AMA\u2010negative PBC\u2019. The second was made up of another 12 PBC patients with positive AMA.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Antimitochondrial antibodies\u2010negative\/positive patients were remarkably similar in terms of clinical manifestations, liver biochemistries and histological findings. The frequency of anti\u2010nuclear antibodies, anti\u2010smooth\u2010muscle antibody, anti\u2010gp210 and anti\u2010sp100 antibody showed no significant difference between the two groups. A significantly lower mean percentage of CD4<jats:sup>+<\/jats:sup>CD25<jats:sup>high<\/jats:sup> T cells was observed in peripheral blood mononuclear cells of AMA\u2010negative\/positive PBC patients compared with that of the 12 control subjects (5.8\u00b11.8 and 5.4\u00b11.4% vs. 7.6\u00b11.7% respectively; <jats:italic>P<\/jats:italic>=0.014 and 0.004). However, no difference could be found between AMA\u2010negative and AMA\u2010positive PBC patients (<jats:italic>P<\/jats:italic>=0.599). After 1 year treatment with ursodeoxycholic acid, the two groups showed similar response.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> Antimitochondrial antibody\u2010negative\/positive PBC patients are similar in clinical, laboratory, percentage of Treg in peripheral blood, liver biopsy features and response to treatment. This suggests that AMA\u2010negative PBC may be a variant of AMA\u2010positive PBC rather than a separate clinical entity.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2007.01651.x","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T13:16:25Z","timestamp":1282914985000},"page":"233-239","source":"Crossref","is-referenced-by-count":39,"title":["Antimitochondrial antibody\u2010negative primary biliary cirrhosis: a subset of primary biliary cirrhosis"],"prefix":"10.1111","volume":"28","author":[{"given":"Bin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu Hua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Xia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,1,31]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043898"},{"key":"e_1_2_6_3_2","first-page":"247","article-title":"Antimitochondrial antibody\u2010negative primary biliary cirrhosis","volume":"90","author":"Lacerda MA","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_4_2","first-page":"10","article-title":"Autoimmune cholangiopathy","volume":"18","author":"Ben\u2010Ari Z","year":"1993","journal-title":"part of the spectrum of autoimmune chronic active hepatitis"},{"key":"e_1_2_6_5_2","first-page":"260","article-title":"Antimitochondrial antibody negative primary biliary cirrhosis","volume":"35","author":"Michieletti P","year":"1994","journal-title":"a distinct syndrome of autoimmune cholangitis"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90143-4"},{"key":"e_1_2_6_7_2","first-page":"1232","article-title":"Autoimmune cholangitis","volume":"40","author":"Goodman ZD","year":"1995","journal-title":"a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90427-8"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5984"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230512"},{"key":"e_1_2_6_11_2","first-page":"1","article-title":"Prognosis in primary biliary cirrhosis","volume":"10","author":"Dickson ER","year":"1989","journal-title":"model for decision making"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432479"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80098-1"},{"key":"e_1_2_6_14_2","first-page":"545","article-title":"Serological markers of primary biliary cirrhosis","volume":"15","author":"Bassendine MF","year":"1992","journal-title":"diagnosis, prognosis and subsets"},{"key":"e_1_2_6_15_2","first-page":"506","article-title":"Antimitochondrial antibody in primary biliary cirrhosis","volume":"9","author":"Shi XH","year":"2005","journal-title":"Chin J Rheumatol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198905253202104"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005350170151"},{"key":"e_1_2_6_18_2","first-page":"212","volume-title":"Diseases of the Liver and Biliary System","author":"Sherlock S.","year":"1989"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250507"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260103"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90078-7"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21678"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hepres.2003.09.003"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2006.04.005"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni0901-816"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21385"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21123"},{"key":"e_1_2_6_28_2","first-page":"1122","article-title":"Human anergic\/suppressive CD4 (+)CD25 (+) T cells","volume":"31","author":"Taams LS","year":"2001","journal-title":"a highly differentiated and apoptosis-prone population"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.10.7.1243"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290126"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02377.x"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2007.01651.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2007.01651.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T09:19:56Z","timestamp":1697102396000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2007.01651.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,31]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1478-3231.2007.01651.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2007.01651.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,31]]}}}